[HTML][HTML] Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

…, M Solis, E Laugel, N Reix, A Schneider, L Glady… - …, 2021 - thelancet.com
Background Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting
risk of reinfection and durability of vaccine protection. Methods This is a prospective, …

Sex differences in the evolution of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2

…, D Rey, H Mouquet, N Reix, L Glady… - The Journal of …, 2021 - academic.oup.com
We measured anti-spike (S), nucleoprotein (N), and neutralizing antibodies in sera from 308
healthcare workers with a positive reverse-transcription quantitative polymerase chain …

Anti-SARS-CoV-2 antibodies persist for up to 13 months and reduce risk of reinfection

…, M Solis, E Laugel, N Reix, A Schneider, L Glady… - Medrxiv, 2021 - medrxiv.org
Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting protection
against reinfection and durability of vaccine protection. Here, we longitudinally measured …

POCT-management during the first wave of Covid-19 in France. Results of a national survey leaded by the SFBC-POCT Working Group

L Glady, V Moal, I Benz-De Bretagne… - Annales de Biologie …, 2021 - europepmc.org
During the first wave of Covid-19 in France, in spring 2020, healthcare institution's laboratory
had to adapt itself quickly to the growing demand for emergency biology, in particular by …

Interleukin-6 chemiluminescent immunoassay on Lumipulse G600 II: analytical evaluation and comparison with three other laboratory analyzers

L Glady, T Lavaux, R Charchour, JM Lacorte… - Clinical Chemistry and …, 2020 - degruyter.com
Ludovic Glady EMAIL logo , Thomas Lavaux , Rim Charchour , Jean-Marc Lacorte and
Jean-Marc Lessinger … Ludovic Glady, Pharm D, Clinical Biochemistry and Molecular …

[HTML][HTML] Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol …

M Muller, F Lefebvre, ML Harlay, L Glady, G Becker… - Trials, 2021 - Springer
Objectives The main objective of this study is to evaluate the effect of intravenous lidocaine
on gas exchange and inflammation in acute respiratory distress syndrome due or not to Covid…

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France

…, S Bayer, N Reix, A Schneider, L Glady… - Infectious Diseases …, 2022 - Elsevier
Objectives Strasbourg University Hospital faced an important COVID-19 first wave from early
March 2020. We performed a longitudinal prospective cohort study to describe clinical and …

Evolution of human antibody responses up to one year after SARS-CoV-2 infection

…, M Solis, E Laugel, N Reix, A Schneider, L Glady… - 2021 - pesquisa.bvsalud.org
Assessment of the kinetics of SARS-CoV-2 antibodies is essential to predict protection against
reinfection and durability of vaccine protection. Here, we longitudinally measured Spike (S…

Cod: T070

LG De Guadiana-Romualdo, P Esteban-Torrella… - degruyter.com
Background Urinary tract infection (UTI) is a commonly handled condition in the emergency
department (ED). Febrile UTI (fUTI) is a potentially serious infection with a mortality rate of …

Gestion de la biologie délocalisée lors de la première vague de Covid-19 en France. Résultats de l'enquête nationale menée par le groupe de travail des EBMD de la …

L Glady, V Moal, BD Bretagne… - Annales de Biologie …, 2021 - search.ebscohost.com
Au printemps 2020, lors de la première vague de Covid-19 en France, les laboratoires de
biologie médicale des établissements de santé ont dû s' adapter rapidement aux demandes …